Development of an Intracellular Nitric Oxide-Donating Cell-Penetrating Polypeptide as an Immunogenic Cell Death

Naeun Kim1, Susam Lee1, Heewon Park1

  • 1Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.

ACS Applied Bio Materials
|October 11, 2024
PubMed

Insights

This study introduces poly(l-guanidine) (PLG), a novel polypeptide that generates nitric oxide (NO) within tumor cells. This NO then effectively triggers immunogenic cell death (ICD) via endoplasmic reticulum stress and mitochondrial pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Nitric oxide (NO) induces tumor cell immunogenic cell death (ICD) via endoplasmic reticulum (ER) stress and mitochondrial outer membrane permeabilization (MOMP).
  • The instability of NO poses challenges for direct therapeutic delivery.
  • Developing effective NO delivery systems is crucial for cancer immunotherapy.

Purpose of the Study:

  • To develop a novel, cell-penetrating polypeptide-based nitric oxide (NO) donor for inducing immunogenic cell death (ICD) in tumor cells.
  • To investigate the mechanisms by which the NO donor generates NO intracellularly and triggers ICD.

Main Methods:

  • Synthesis of a cell-penetrating polypeptide, poly(l-guanidine) (PLG).
  • Investigation of PLG's ability to penetrate cells and generate reactive oxygen species (ROS).
  • Analysis of NO production via guanidine oxidation catalyzed by intracellular ROS.
  • Assessment of ICD induction through ER stress and MOMP markers.

Main Results:

  • Helical PLG demonstrated spontaneous cell penetration and intracellular ROS generation.
  • PLG effectively produced NO through self-inducible guanidine oxidation within cells.
  • The generated NO induced ICD by activating ER stress and MOMP-dependent pathways.

Conclusions:

  • Poly(l-guanidine) (PLG) serves as an effective intracellular nitric oxide (NO) donor.
  • PLG-mediated NO generation successfully induces tumor cell immunogenic cell death (ICD).
  • The findings highlight PLG as a promising platform for cancer therapy leveraging NO-induced ICD.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.7K